IOVA (STOCKS)
Iovance Biotherapeutics, Inc. Common Stock
$4.029400
-0.050600 (-1.24%)
Prev close: $4.080000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Frederick G. Vogt
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,801.64M
- Employees
- 838
- P/E (TTM)
- -4.24
- P/B (TTM)
- 2.48
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
10
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.19 | $-0.15 | -0.0372 | -24.35% |
|
Dec 2025 (Q4)
|
$-0.18 | $-0.18 | -0.0049 | -2.80% |
|
Sep 2025 (Q3)
|
$-0.25 | $-0.26 | +0.0132 | +5.02% |
|
Jun 2025 (Q2)
|
$-0.33 | $-0.29 | -0.0398 | -13.71% |
Financial Statements
| Assets | $925.67M |
| Current Assets | $466.50M |
| Inventory | $58.38M |
| Other Current Assets | $408.13M |
| Noncurrent Assets | $459.16M |
| Fixed Assets | $131.39M |
| Other Non-current Assets | $327.77M |
| Liabilities | $203.91M |
| Current Liabilities | $129.42M |
| Accounts Payable | $37.45M |
| Other Current Liabilities | $91.97M |
| Noncurrent Liabilities | $74.49M |
| Equity | $721.75M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $721.75M |
| Liabilities And Equity | $925.67M |